Apyx Medical Corporation (APYX)
NASDAQ: APYX · Real-Time Price · USD
3.940
+0.070 (1.81%)
At close: May 19, 2026, 4:00 PM EDT
3.940
0.00 (0.00%)
After-hours: May 19, 2026, 4:00 PM EDT

Apyx Medical Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
167146609181441
Market Cap Growth
254.48%144.92%-34.21%12.12%-81.65%78.68%
Enterprise Value
171.46153.7166.5185.4771.52410.59
Last Close Price
3.943.501.582.622.3412.82
PS Ratio
2.922.771.241.731.829.09
PB Ratio
12.6310.064.203.402.158.21
P/TBV Ratio
12.859.893.953.402.158.20
EV/Sales Ratio
3.072.911.381.631.618.46
Debt / Equity Ratio
2.982.622.681.420.010.00
Net Debt / Equity Ratio
0.650.520.49-0.19-0.25-0.57
Net Debt / EBITDA Ratio
-2.32-1.31-0.380.310.412.26
Net Debt / FCF Ratio
-0.93-0.83-0.370.890.442.74
Asset Turnover
0.860.800.670.800.740.68
Inventory Turnover
2.272.452.141.711.662.75
Quick Ratio
4.654.154.404.532.403.94
Current Ratio
5.805.005.265.523.634.60
Return on Equity (ROE)
-65.02%-76.15%-114.21%-58.26%-50.71%-25.79%
Return on Assets (ROA)
-6.91%-10.03%-26.44%-23.34%-39.73%-20.75%
Return on Invested Capital (ROIC)
-19.21%-28.38%-82.91%-57.47%-87.18%-61.31%
Return on Capital Employed (ROCE)
-7.92%-11.80%-31.25%-32.43%-49.38%-23.99%
Buyback Yield / Dilution
-10.75%-15.62%-2.66%-0.31%-0.54%-0.35%
Total Shareholder Return
-10.75%-15.62%-2.66%-0.31%-0.54%-0.35%
Updated May 7, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q